Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Dermatologic 1

Conditions

Vomiting 2Testicular Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Carcinoma, Renal Cell 1

Interventions

Dexamethasone 3Aprepitant 3fosaprepitant 2Granisetron 2Calcium Dobesilate 2lerisetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1Therapeutics 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Radiotherapy 1Psychiatric Rehabilitation 1Ondansetron 1Olanzapine 1Massage 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Cyclophosphamide 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vomiting × fosaprepitant × Genitourinary × Clear all
NCT01874119 2018-06-07

HDIL2/Emend

St. Louis University

Phase 2 Terminated
13 enrolled 7 charts
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Vomiting

NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Hoosier Cancer Research Network

Phase 2 Completed
65 enrolled 14 charts
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡